Answers are grounded in this paper and cite their sources.
Background and ObjectivesSpinocerebellar ataxias are genetically heterogeneous neurodegenerative disorders characterized by progressive cerebellar degeneration. Among them, SCA7 and SCA8 are particularly rare, and their longitudinal natural history has not been well defined. Using data from the Clinical Research Consortium for the Study of Cerebellar Ataxias, we examined disease progression in genetically confirmed SCA7 and SCA8 patients in North America. MethodsLongitudinal changes in motor severity were assessed using the Scale for the Assessment and Rating of Ataxia (SARA), alongside cognitive function (Cerebellar Cognitive Affective Syndrome scale [CCAS]) and depressive symptoms (Patient Health Questionnaire-9 (PHQ-9)), applying linear mixed-effects models with genetic and clinical covariates. Our cohort included 27 individuals with SCA7 and 51 with SCA8 with baseline data, among which 22 individuals with SCA7 and 42 with SCA8 have longitudinal follow-up. ResultsAge at onset in SCA7 was inversely associated with pathologic repeat length (β = −1.43, p < 0.01), whereas no significant correlation was observed in SCA8 (β = −0.08, p = 0.28). Longitudinal analyses demonstrated that SCA7 progressed relatively rapidly, with SARA scores worsening by 1.68 points per year, while SCA8 showed substantially slower progression at 0.47 points per year. In both disorders, progression was predominantly driven by deterioration in the axial SARA domain, particularly gait and stance. In contrast, CCAS and PHQ-9 scores remained stable over approximately 5 years of follow-up, with no significant longitudinal changes detected. DiscussionThese findings demonstrate distinct disease trajectories between SCA7 and SCA8 to inform future longitudinal studies and therapeutic trials.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: